Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAD23 homolog B pseudogene 1 (RAD23BP1) is a human pseudogene that is related in sequence to the functional RAD23B gene, which encodes a protein involved in nucleotide excision repair and ubiquitin-mediated protein degradation[5][6]. However, unlike its functional counterpart, RAD23BP1 does not code for a protein and has no known physiological or clinical significance. There is no evidence that RAD23BP1 acts as a therapeutic target, biomarker, or disease modifier.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAD23 homolog B pseudogene 1 (RAD23BP1).